Zachary Roberts

EVP of R&D, Allogene Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Feb 2, 2026

Companies

Allogene Therapeutics, Inc.EVP of R&D −$0.1M

Trades

ALLO Sold 35,700 shares at $1.77 $0.1M Feb 2

ALLO Sold 26,269 shares at $1.56 $0.0M Jan 21

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.